drugset / Trial / NCT03300674

Intravenous Lidocaine Randomized Comparative Effectiveness Trial

NCT03300674

Phase 4 Completed 154 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blind, emergency department based, comparative effectiveness study of two medication for acute abdominal pain: intravenous lidocaine and intravenous hydromorphone. Patients will be enrolled during an emergency department visit and followed throughout their emergency department course and then by telephone 7 days later.

Timeline

Start
2018-01-10
Primary completion
2018-08-16
Completion
2018-08-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydromorphone Other / unclassified 1 mg Intravenous
Comparator Lidocaine Other / unclassified 120 mg Intravenous

Indications

No indication recorded.